Research & Development



  這家伙死掉了,算是為大漢捐軀,活著,就能享受榮華富貴,算起來,雲瑯不覺得虧欠了他什麼。   匈奴人的箭法很好,只是狼牙箭在霍去病的甲冑上劃出一道白印就不知道飛去了那里。超碰在线视频97   謝長川用這批人去對付同樣神出鬼沒的韓地叛賊,堪稱明智之極。大香蕉网   這些人也就是因為不會讀書,才能安守現在的環境,一旦他們讀書識字了,個頂個的是人間老奸賊。   “所以啊,我們要成為老虎,豹子,狼,不但要有尖牙利爪,還要有速度!”伊人在线大香蕉

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo